The DIGI-B-CUBE project aims to unlock the cross-sectoral collaborative potential of SMEs by combining Artificial Intelligence (AI), Cognitive Computing Digital Technologies (CCDT) with the Bioimaging-Biosensing-Biobanking (B-CUBE) industries to deliver market sensitive disruptive technologies and generating innovative solutions that enhance patient-centred diagnostic work-flows, delivered through the improved algorithms for Medical Diagnostics’ efficiency and accuracy. By integrating innovations in IT into Bioimaging, Biosensing and Biobanking industries, this project will accelerate the goal of personalised medicine that can eventually offer patients with fast and efficient diagnosis-treatment-healthcare system. Digital innovations will reconfigure how health treatment is provided and will lead to more effective diagnosis and will enable precision medicine.
B-CUBE is an abbreviation for Bioimaging, Biosensing and Biobanking:
- Bioimaging, or biological imaging, refers to when creating images of the human body or parts of it to diagnose or examine disease.
- Biosensing is the measurement of a chemical substance, for example glucose monitoring in diabetes patients or other medical health related targets
- Biobanking is the storing of human biological samples so that they can be used for medical research later.
DIGI-B-CUBE will foster the development of customized solutions and prototypes by providing innovative small and medium-sized enterprises (SMEs) in the EU and Associated Countries with access to vouchers of up to € 60,000. The voucher scheme call will be launched in April 2020, but SMEs can start engaging in the project’s activities in the coming months by participating in the project´s sectoral and cross-sectoral workshops as well as matchmaking sessions.
